Please login to the form below

Not currently logged in
Email:
Password:

sitagliptin

This page shows the latest sitagliptin news and features for those working in and with pharma, biotech and healthcare.

Givlaari, Rybelsus lead crowded CHMP recommendations

Givlaari, Rybelsus lead crowded CHMP recommendations

In Novo’s Pioneer programme of the drug, people treated with Rybelsus achieved greater blood glucose reductions compared to Merck &Co’s DPP-4 inhibitor Januvia (sitagliptin), Boehringer Ingelheim and Eli

Latest news

More from news
Approximately 8 fully matching, plus 88 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...
Digital technologies: Pharma’s answer to achieving net zero emissions?
...